Shujun Lin
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- PI3K/AKT/mTOR signaling in cancer
- Cancer-related gene regulation
- RNA modifications and cancer
Papers in
-
- Ubiquitin and proteasome pathways 4
-
- Renal Diseases and Glomerulopathies 4
- Co-authors
- Juergen Kast (7 shared papers)Tian‐Biao Zhou (17 shared papers)Pietri Puustinen (2 shared papers)Melissa R. Junttila (2 shared papers)Jukka Westermarck (2 shared papers)Fábio Rossi (3 shared papers)Tuula Kallunki (1 shared paper)Hugh Arnold (1 shared paper)
- Journals
- Drug Design Development and Therapy (3 papers)Journal of Proteome Research (2 papers)Stem Cell Research & Therapy (2 papers)BioMed Research International (2 papers)Transfusion (1 paper)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Shujun Lin
47 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 354
- Molecular Biology 822
- Cancer Research 179
- Hematology 123
- Genetics 117
Countries citing papers authored by Shujun Lin
This map shows the geographic impact of Shujun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shujun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shujun Lin more than expected).
Fields of papers citing papers by Shujun Lin
This network shows the impact of papers produced by Shujun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shujun Lin. The network helps show where Shujun Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Shujun Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CIP2A Inhibits PP2A in Human Malignancies Hit paper breakdown → | 2007 | 533 |
| 2 | 2012 | 115 | |
| 3 | 2009 | 86 | |
| 4 | 2009 | 81 | |
| 5 | 2019 | 74 | |
| 6 | 2007 | 70 | |
| 7 | 2011 | 63 | |
| 8 | 2020 | 50 | |
| 9 | 2008 | 31 | |
| 10 | 2020 | 30 | |
| 11 | 2022 | 28 | |
| 12 | 2021 | 26 | |
| 13 | 2006 | 25 | |
| 14 | 2020 | 22 | |
| 15 | 2019 | 19 | |
| 16 | 2020 | 16 | |
| 17 | 2019 | 15 | |
| 18 | 2020 | 12 | |
| 19 | 2019 | 12 | |
| 20 | 2016 | 12 |
About Shujun Lin
Shujun Lin is a scholar working on Molecular Biology, Nephrology, Genetics, Oncology and Cancer Research, having authored 49 papers that have together received 1.4k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (6 papers), Renal Diseases and Glomerulopathies (4 papers), Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (3 papers), Neuroscience and Neuropharmacology Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), MicroRNA in disease regulation (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Oncology (354 citations), Molecular Biology (822 citations), Cancer Research (179 citations), Hematology (123 citations) and Genetics (117 citations). Shujun Lin has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Juergen Kast, Tian‐Biao Zhou, Pietri Puustinen, Melissa R. Junttila, Jukka Westermarck, Fábio Rossi, Tuula Kallunki, Hugh Arnold, Edward K. L. Chan and Trine Bøttzauw. Their work appears in journals such as Drug Design Development and Therapy, Journal of Proteome Research, Stem Cell Research & Therapy, BioMed Research International and Transfusion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.